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Abstract
This scientiﬁc opinion of the EFSA Panel on Food Contact Materials, Enzymes, Flavourings and
Processing Aids (CEF Panel) deals with the safety assessment of the substance phosphorous acid,
mixed 2,4-bis(1,1-dimethylpropyl)phenyl and 4-(1,1-dimethylpropyl)phenyl triesters. The substance
was evaluated by the CEF Panel in 2011 and 2,4-di-tert-amylphenol, an impurity and hydrolysis
product was re-evaluated by the CEF Panel in 2015. In this application, the applicant requested an
increase of the speciﬁc migration limit of the substance, currently established at 5 mg/kg food, to
10 mg/kg food, and provided new toxicological studies. Findings from three new in vitro mutagenicity
assays on the oxidation products support the conclusion from 2011 that the substance and its
oxidation products are not genotoxic. A new toxicokinetic study on the substance supports the
consideration from the evaluation in 2011 that the substance does not raise concern for accumulation.
The outcome of a new delayed neurotoxicity study on a structurally related substance, phosphorous
acid, tris (2,4-di-tert-butylphenyl) ester, which was considered not to cause neurotoxicity in hens,
strengthens the conclusion of the Panel in 2011 that the substance does not represent a concern for
neurotoxicity. From a new two-generation reproduction toxicity study and a prenatal developmental
toxicity study on the substance, a new subchronic toxicity study on its oxidation products that
completes the one submitted in 2011 on the substance itself, and a 2-year oral toxicity study on the
structurally related substance, the lowest NOAEL was 58–147 mg/kg bw per day (from the 2-year oral
toxicity study). Compared to the requested increase of the migration limit, this gives an acceptable
margin of safety of 348. Therefore, the CEF Panel concluded that an increase of the speciﬁc migration
limit of the substance from 5 to 10 mg/kg food is not a safety concern for the consumer.
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1. Introduction
1.1. Background and Terms of Reference as provided by the requestor
Before a substance is authorised to be used in food contact materials (FCM) and included in a
positive list, EFSA’s opinion on its safety is required. This procedure has been established in Articles 8,
9 and 10 of Regulation (EC) No 1935/2004 of the European Parliament and of the Council of 27
October 2004 on materials and articles intended to come into contact with food.
According to this procedure, the industry submits applications to the Member States’ competent
authorities which transmit the applications to the European Food Safety Authority (EFSA) for their
evaluation.
In this case, EFSA received an application from Food Standards Agency, the United Kingdom,
requesting a re-evaluation of the substance phosphorous acid, mixed 2,4-bis(1,1-dimethylpropyl)
phenyl and 4-(1,1-dimethylpropyl)phenyl triesters, with the CAS number 939402-02-5, the PM Ref.
No 74050 and the FCM substance No 974. The dossier was submitted on behalf of Addivant.
According to Regulation (EC) No 1935/2004 of the European Parliament and of the Council on
materials and articles intended to come into contact with food, EFSA is asked to carry out an
assessment of the risks related to the intended use of the substance and to deliver a scientiﬁc opinion.
2. Data and methodologies
2.1. Data
The applicant has submitted a dossier in support of their application for a revision of the
authorisation of phosphorous acid, mixed 2,4-bis(1,1-dimethylpropyl)phenyl and 4-(1,1-dimethylpropyl)
phenyl triesters, to be used in FCM. Data submitted and used for the evaluation are:
Non-toxicological data and information:
• Chemical identity
• Intended use
• Existing authorisation(s).
Toxicological data:
• Bacterial gene mutation test on the phosphate form of the substance
• In vitro mammalian cell gene mutation test on the phosphate form of the substance
• In vitro mammalian chromosome aberration test on the phosphate form of the substance
• 91-day oral toxicity study in rats on the phosphate form of the substance
• Two-generation reproduction toxicity study on the substance (phosphite form)
• Prenatal development toxicity study on the substance (phosphite form)
• ADME on the substance (phosphite form)
• ADME on a structurally related substance (phosphorous acid, tris (2,4-di-tert-butylphenyl)
ester)
• Delayed neurotoxicity study in hens on a structurally related substance (phosphorous acid, tris
(2,4-di-tert-butylphenyl) ester)
• Combined chronic/carcinogenicity oral rat study on a structurally related substance
(phosphorous acid, tris (2,4-di-tert-butylphenyl) ester).
2.2. Methodologies
The assessment was conducted in line with the principles laid down in Regulation (EC) No 1935/2004
on materials and articles intended to come into contact with food. This Regulation underlines that
applicants may consult the Guidelines of the Scientiﬁc Committee on Food (SCF) for the presentation
of an application for safety assessment of a substance to be used in FCM prior to its authorisation
(European Commission, 2001), including the corresponding data requirements. The dossier that the
applicant submitted for evaluation was in line with the SCF guidelines (European Commission, 2001).
The methodology is based on the characterisation of the substance(s) that is subject of the request
for safety assessment prior to authorisation, its impurities and reaction and degradation products, the
evaluation of the exposure to those substances through migration, and the deﬁnition of minimum sets
of toxicity data required for safety assessment.
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To establish the safety from ingestion of migrating substances, the toxicological data indicating the
potential hazard and the likely human exposure data need to be combined. Exposure is estimated from
studies on migration into food or food simulants and considering that a person may consume daily up
to 1 kg of food in contact with the relevant FCM.
As a general rule, the greater the exposure through migration, the more toxicological data is
required for the safety assessment of a substance. Currently, there are three tiers with different
thresholds triggering the need for more toxicological information as follows:
a) In case of high migration (i.e. 5–60 mg/kg food), an extensive data set is needed.
b) In case of migration between 0.05 and 5 mg/kg food, a reduced data set may sufﬁce.
c) In case of low migration (i.e. < 0.05 mg/kg food), only a limited data set is needed.
More detailed information on the required data is available in the SCF guidelines (European
Commission, 2001).
The assessment was conducted in line with the principles described in the EFSA Guidance on
transparency in the scientiﬁc aspects of risk assessment (EFSA, 2009) and considering the relevant
existing guidance from the EFSA Scientiﬁc Committee.
3. Assessment
The substance phosphorous acid mixed 2,4-bis(1,1-dimethylpropyl)phenyl and 4-(1,1-
dimethylpropyl)phenyl triesters was evaluated for its use as an antioxidant in all polymers by the CEF
Panel in 2011 (EFSA CEF Panel, 2011). The CEF Panel concluded that the substance is not of concern
if its migration does not exceed 5 mg/kg food (expressed as the sum of the phosphite and phosphate
forms of the substance and the hydrolysis product 4-tert-amylphenol). The Panel also concluded that
migration of the hydrolysis product 2,4-di-tert-amylphenol should not exceed 0.05 mg/kg food.
In 2015, the CEF Panel re-evaluated 2,4-di-tert-amylphenol, impurity and hydrolysis product of the
substance, and concluded that it is not a safety concern for the consumer if its migration does not
exceed 1 mg/kg food and it is included in the existing 5 mg/kg food restriction for the phosphorous
acid, mixed 2,4-bis(1,1-dimethylpropyl)phenyl and 4-(1,1-dimethylpropyl)phenyl triesters (EFSA CEF
Panel, 2015). It was proposed to express the restriction of phosphorous acid, mixed 2,4-bis(1,1-
dimethylpropyl)phenyl and 4-(1,1-dimethylpropyl)phenyl triesters as the sum of the phosphite and
phosphate forms of the substance, 4-tert-amylphenol and 2,4-di-tert-amylphenol; in addition the
migration of 2,4-di-tert-amylphenol should not exceed 1 mg/kg food.
In this application, the applicant requests a re-evaluation of the speciﬁc migration limit (SML) for
phosphorous acid, mixed 2,4-bis(1,1-dimethylpropyl)phenyl and 4-(1,1-dimethylpropyl)phenyl triesters,
currently established at 5 mg/kg food, with a view to increase it to 10 mg/kg food. The ﬁnal plastics
containing the antioxidant are intended to come into contact with all types of food for short term
contact at high temperatures and long term storage at or below room temperature.
3.1. Non-toxicological data
Note to the reader: Two different names are used in this Opinion to describe the same 5-carbon
structural unit. These names are 1,1-dimethylpropyl- and t-amyl- which are common names for the
moiety more systematically named as 2-methylbutan-2-yl. The two common names are used variously,
in order to be consistent with the naming of the parent substances (i.e. substances containing that
5-carbon unit) in previous Opinions and in EU FCM Regulations.
The substance is a deﬁned mixture in which the components are:
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From the previous evaluations (EFSA CEF Panel, 2011, 2015), the migration of the substance from
high-density polyethylene (HDPE) and linear low-density polyethylene (LLDPE) was not detectable in any
simulant used (3% acetic acid, 10% ethanol, olive oil; after 2 h at 100°C followed by 10 days at 40°C) at
the detection limit of 20 lg/kg. The oxidised form (phosphate form) was found in olive oil at levels up to
20.9 mg/kg. 4-t-Amylphenol was detected in water, 3% acetic acid, 10% ethanol and olive oil at levels
up to 1.1 mg/kg. 2,4-di-t-Amylphenol was detected only in olive oil and was up to 0.1 mg/kg. In mixed-
character foods (e.g. both fatty and acidic), hydrolysis of migrated antioxidant might result in higher
concentrations.
3.2. Toxicological data
Data on the applied substance (phosphite form) and its oxidation products (phosphate form) have
been provided for toxicokinetics, genotoxicity, subchronic toxicity, reproduction and prenatal
developmental toxicity.
- Phosphorous acid, 4-(1,1-dimethylpropyl)phenyl triesters (24–60% w/w)
O P
3
(C33H45O3P, MW= 520.7 Da)
- Phosphorous acid, [2,4-bis(1,1-dimethylpropyl)phenyl] bis[4-(1,1-dimethylpropyl)phenyl] esters 
(25–50% w/w)
O P
2
O
(C38H55O3P, MW= 590.8 Da)
- Phosphorous acid, bis[2,4-bis(1,1-dimethylpropyl)phenyl] [4-(1,1-dimethylpropyl)phenyl] esters 
(1–15% w/w)
O P
O
2
(C43H65O3P, MW= 660.9 Da)
- Phosphorous acid, mixed 2,4-bis(1,1-dimethylpropyl)phenyl triesters (0–5% w/w)
O P
3
(C48H75O3P, MW= 731.1 Da)
- Impurities and hydrolysis products, 4-t-amylphenol and 2,4-di-t-amylphenol
Figure 1: Chemical structures of the substance phosphorous acid mixed 2,4-bis(1,1-dimethylpropyl)
phenyl and 4-(1,1-dimethylpropyl)phenyl triesters and of its impurities and hydrolysis
products 4-t-amylphenol and 2,4-di-t-amylphenol
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In addition, data on toxicokinetics, combined chronic toxicity/carcinogenicity and delayed
neurotoxicity have been submitted for phosphorous acid, tris (2,4-di-tert-butylphenyl) ester (Figure 2;
FCM No 671, CAS No 31570-04-4), i.e. the ‘source substance’ to read across to the applied substance,
i.e. the ‘target substance’ (one methyl group difference in each of the alkyl substituents). The source
substance has been evaluated in the past by the SCF (European Commission, 1999) and was also
considered in the evaluation by the EFSA CEF Panel in 2011 (EFSA CEF Panel, 2011). In view of the
structural and physicochemical similarities, and a similar toxicokinetic behaviour (see below), the
Panel considered the read across from the source substance acceptable.
Toxicokinetics
In its evaluation in 2011 (EFSA CEF Panel, 2011), the CEF Panel considered a toxicokinetic study in
Wistar rats performed on a structurally similar substance, i.e. 14C-bis(2,4-di-tert-butylphenyl)
pentaerythritol diphosphite. Based on the results of that study, the CEF Panel concluded that the
applied substance does not raise concern for accumulation despite its high log Po/w value.
In this application, a new toxicokinetic study (absorption, distribution, metabolism, and excretion
(ADME)) in rats according to OECD TG No 417 was provided on the substance (non-oxidised form;
phosphite). The substance was administered by oral gavage to Wistar rats (4 rats/sex per group) at
single doses of 100 or 1,000 mg/kg, or a repeated dose for 14 days of 100 mg/kg per day. The test
item was excreted within 48 h (81–92% of the dose) mainly via faeces, whereas excretion via urine
was minor. Following single or repeated doses of the test item, animals were euthanised 48 h post-
dosing. The average radioactivity remaining in blood, carcass and tissues was < 1% of the
administered dose. In line with the results of the toxicokinetic study evaluated in 2011 on 14C-bis(2,4-
di-tert-butylphenyl)pentaerythritol diphosphite, the data suggest that the substance was poorly
absorbed and/or rapidly excreted and not accumulated in the body. These results support the 2011
conclusion that the applied substance does not raise concern for accumulation in human despite its
high log Po/w value.
In view of the read across, the Panel also considered an ADME study on phenyl ring U-14C
radiolabelled phosphorous acid, tris (2,4-di-tert-butylphenyl) ester. The fate of that source substance
was investigated in male Sprague–Dawley rats administered by gavage with a single dose of 0.26 or
5.30 mg/kg body weight (bw). After 72 h, less than 0.02% of the dose was found in the body of the
rats, the radioactivity being excreted nearly completely in the faeces (94.5–97.1% of the dose) and to
a very small extent in urine (0.1–0.4% of the dose). Results between the source and target substances
are basically consistent, although the Panel noted some minor uncertainties due to different dosing
regimens applied in the studies and to quantitative differences in the urinary excretion levels.
Genotoxicity
In 2011, the CEF Panel evaluated the potential genotoxicity of the substance (i.e. in its phosphite
form) from three in vitro genotoxicity tests and concluded that the substance was non-genotoxic
(EFSA CEF Panel, 2011). The CEF Panel noted that under the conditions of the genotoxicity tests, also
the oxidation products of the substance were tested.
In this application, three new in vitro genotoxicity assays were performed on the phosphate form of
the substance (with a recorded purity of 100%) in the presence and absence of metabolic activation
up to the solubility limit, according to OECD guidelines and Good Laboratory Practice (GLP). The
substance, tested for bacterial mutation using Salmonella Typhimurium strains TA98, TA100, TA1535,
TA1537 and Escherichia coli WP2 uvrA, did not increase the number of revertants compared to the
vehicle control. When the substance was tested for the ability to induce forward mutations at the
thymidine-kinase locus (TK-locus) in L5178Y mouse lymphoma cells in two experiments, no increase in
the mutation frequency compared to the vehicle control was observed. Likewise, when the substance
O P
3 (C42H63O3P, MW= 646.92 Da)
Figure 2: Chemical structure of the source substance for read-across; phosphorous acid, tris (2,4-
di-tert-butylphenyl) ester
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was tested in two separate experiments in an in vitro chromosomal aberration assay in human
lymphocytes no increase of chromosomal damage compared to the vehicle control was observed.
Therefore, the above results conﬁrm the conclusion drawn in 2011, that both the phosphite and the
phosphate forms do not raise concern for genotoxicity.
Subchronic toxicity
In 2011, the CEF Panel evaluated a 90-day oral toxicity study carried out in rats with the phosphite
form of the substance. It resulted in minor treatment-related changes. Increases in liver weights
(approx. 10%) for the females treated with 20,000 ppm in the feed along with increased cholesterol
levels (20%) and dose-dependent increases of alkaline phosphatase levels were considered adverse.
The ‘no observed adverse effect level’ (NOAEL) was considered to be 10,000 ppm in the feed,
equivalent to 759 mg/kg bw per day based on effects in liver.
In this application, the phosphate form of the substance was administered in a OECD TG No 408
guideline study by oral gavage to Sprague–Dawley rats, for 91 consecutive days, at dose levels of 0
(control), 100, 300 and 1,000 mg/kg bw per day followed by a recovery study of 28 days (0 and
1,000 mg/kg bw). Mild prolongations of activated partial thromboplastin time were noted at
termination in both sexes of the 1,000 mg/kg bw per day group when compared to the control and
prothrombin time was also minimally prolonged in the males at this dose level. There was a
statistically signiﬁcant increase of cholesterol in females (up to 22%) of the 1,000 mg/kg bw per day
group when compared to control. These ﬁndings were considered treatment related by the Panel,
since also increased cholesterol levels in the 90-day oral toxicity study carried out in rats with the
phosphite form of the substance were identiﬁed in 2011. No other signs of either systemic toxicity or
neurobehavioral effects were evident during the main or recovery phases of the study. Therefore, the
NOAEL was determined to be 300 mg/kg bw per day.
Reproduction toxicity
In a two-generation reproduction toxicity study (OECD TG No 416) submitted in this application, the
substance (phosphite form) was administered to Wistar Han rats orally in the diet at dose levels of 0
(control), 1,500 (87–116 mg/kg bw per day (m), 112–128 mg/kg bw per day (f)), 5,000 (278–399 mg/kg
bw per day (m), 372–434 mg/kg bw per day (f)) and 15,000 ppm (943–1,254 mg/kg bw per day (m),
1,141–1,365 mg/kg bw per day (f)) from 10 weeks prior to mating until euthanasia (males) or 1 day
before euthanasia (females). Higher relative kidney weights were noted in both sexes of the F0
generation (10.8% males, 8.1% females), and increased absolute kidney weights were also noted in
the F0 males (7.4%) at the 15,000 ppm dose level. Reduced bodyweights (7.3% (F1; m) and 6.3%
(F0 and F1; f)) were observed despite an increased food consumption, indicating general systemic
toxicity. Although the magnitude of the reduction was less than 10%, reduced body weights was also
identiﬁed in the prenatal developmental study on this substance, therefore it was considered to be of
toxicological relevance. The reproduction and developmental NOAELs were therefore considered by the
Panel to be the 5,000 ppm dose level which corresponds for males to 278–399 mg/kg bw per day.
Prenatal developmental toxicity
In this application, the substance (phosphite form) was administered in a OECD TG No 414
prenatal developmental toxicity study orally (in the diet) to female Wistar Han rats from days 6 to 20
post-coitum at dose levels of 0 (control), 1,500, 5,000, 15,000 ppm, corresponding to a mean test
substance intake of 0, 128, 439 and 1,266 mg/kg bw per day, respectively. Under the conditions of
this prenatal developmental toxicity study, there were no effects on pregnancy and foetuses. The
bodyweight decrease was close to 10% compared to controls, and a similar decrease in bodyweight
was observed in the reproductive toxicity study. Therefore, the maternal NOAEL was considered by the
Panel to be 5,000 ppm (439 mg/kg bw per day).
Neurotoxicity
In its evaluation in 2011 (EFSA CEF Panel, 2011), the Panel noted that the oxidation products of
the substance, i.e. the corresponding phosphate esters, have a structural similarity to known inducers
of delayed neurotoxicity (i.e. ortho-esters of tricresyl phosphates and tri-(p-ethylphenyl) phosphate).
In the absence of speciﬁc neurotoxicity studies, the Panel noted that no treatment-related effects in
behaviour or in the functional performance tests were detected in the 90-day oral rat study.
Additionally, the Panel considered the evaluation made in the past on the source substance and
the tolerable daily intake (TDI) of 1 mg/kg bw derived from a 2-year oral rat study (European
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Commission, 1999). The Panel at that time concluded that there was no concern for neurotoxicity of
the applied substance.
In this application, a delayed neurotoxicity study in hens (OECD TG No 418) conducted with the
source substance was provided to rule out any concern for this speciﬁc effect. The source substance
was given at dose levels of 2,150 and 6,000 mg/kg twice at an interval of 21 days. These treatments
revealed no toxic symptoms. Histopathological lesions of the nervous system were absent. Therefore,
it was concluded that the source substance did not cause delayed neurotoxicity in hens. By read
across, a potential concern for delayed neurotoxicity of the applied substance is removed.
Overall, the Panel conﬁrmed that the applied substance does not raise concern for neurotoxicity.
Combined chronic/carcinogenicity study
No study examining the potential chronic toxicity/carcinogenicity of the applied substance
(phosphite form) was provided. Instead the chronic/carcinogenicity study on the source substance that
was reviewed by the SCF in 1999 (European Commission, 1999) was provided. The CEF Panel concurs
with the TDI of 1 mg/kg bw per day that was derived from the NOAEL of 58–147 mg/kg bw per day
(highest dose; no treatment related effects).
The Panel noted that the lowest NOAEL of 300 mg/kg bw per day from the subchronic toxicity
study on the phosphate form of the target substance is higher than the NOAEL of 58–147 mg/kg bw
per day from a 2-year oral rat study of the source substance. Therefore, instead of applying a default
uncertainty factor to the NOAEL from the subchronic study on the target substance, the
Panel considered more appropriate to use the lowest NOAEL from the chronic study on the source
substance for risk assessment. This NOAEL of 58 mg/kg bw per day (corresponding to 3,480 mg/person
per day) would give a margin of safety (MOS) of 348 compared to the requested migration limit to
10 mg/kg food (equivalent to 10 mg/person per day). This MOS is considered sufﬁcient to cover the
uncertainties related to the read across.
4. Conclusions
Having considered the above-mentioned data, the CEF Panel concluded that the substance
phosphorous acid, mixed 2,4-bis(1,1-dimethylpropyl)phenyl and 4-(1,1-dimethylpropyl)phenyl triesters
is not of safety concern for the consumer if used as an additive with a migration limit of 10 mg/kg
food, expressed as the sum of the phosphite and phosphate forms of the substance, 4-tert-amylphenol
and 2,4-di-tert-amylphenol. The migration of 2,4-di-tert-amylphenol should not exceed 1 mg/kg food.
As a remark for the Commission, the substance complies with the criteria for applying the fat
reduction factor (FRF).
Documentation provided to EFSA
1) Initial dossier. February 2016. Submitted on behalf of Addivant.
2) Additional data. June 2016. Submitted on behalf of Addivant.
3) Additional data. February 2017. Submitted on behalf of Addivant.
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CEF Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids
FCM food contact materials
FRF fat reduction factor
GLP good laboratory practice
HDPE high-density polyethylene
LLDPE linear low-density polyethylene
MOS margin of safety
MW molecular weight
NOAEL no observed adverse effect level
OECD Organisation for Economic Co-operation and Development
Po/w octanol/water partition coefﬁcient
SCF Scientiﬁc Committee on Foods
SML speciﬁc migration limit
TDI tolerable daily intake
TG Test guideline
TK thymidine-kinase
Phosphorous acid, mixed 2,4-bis(1,1-dimethylpropyl)phenyl and 4-(1,1-dimethylpropyl)phenyl triesters
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